Episode 21

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral selective estrogen receptor degraders for ER-positive metastatic breast cancer.

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Breast Cancer Update
Breast Cancer Update
This series bridges the gap between research and patient care by providing on-going access to the perspectives and opinions of national and international breast cancer research leaders.

Listen for free